在真多细胞血症和骨髓纤维化中,肝素通路的调节剂
Marina Kremyanskaya1, Yelena Z Ginzburg1, Ronald Hoffman2
1Icahn School of Medicine at Mount Sinai, New York, New York, United States.
Blood
|October 16, 2025
概括
针对肝素通路的新药提供了针对真多细胞血症 (PV) 和骨髓纤维化 (MF) 的新疗法. 这些疗法旨在通过调节这些血液恶性瘤中的铁含量来控制红细胞的产生和纠正贫血.
科学领域:
- 血液学 血液学 血液学
- 铁的新陈代谢 铁的新陈代谢
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝素是铁代谢的关键调节剂,由肝脏产生.
- 肝素的失调与血液恶性瘤,如真多细胞血症 (PV) 和骨髓纤维化 (MF) 有关.
- 目前对PV和MF的治疗有局限性,需要新的治疗方法.
研究的目的:
- 审查针对PV和MF的肝素通路的新兴治疗策略.
- 探索调节肝素的潜力,以控制红细胞瘤和纠正这些条件下的贫血.
- 突出将铁贩运知识转化为血液恶性瘤的新疗法.
主要方法:
- 对影响肝素通路的药物临床开发的审查.
- 在PV和MF中对肝素在铁调节中的作用的分析.
- 对治疗剂的检查,包括肝素激素激剂和抗剂.
主要成果:
- 肝激素激动剂 (例如,rusfertide) 正在开发中,通过降低肝激素来控制与PV相关的红细胞瘤.
- 针对MF相关的贫血,正在开发降低肝素的策略 (例如,JAK2抑制剂,抗hemojuvelin抗体).
- 这些方法旨在使PV和MF患者的红色素形成正常化.
结论:
- 调节肝素为PV和MF提供了有前途的治疗途径.
- 针对铁贩运,为患有这些血液性恶性瘤的患者提供了新的治疗选择.
- 了解肝素的作用对于开发有效的血液癌症治疗方法至关重要.
相关概念视频
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Factors Affecting Erythropoiesis
5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K
Erythropoiesis
5.7K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.7K


